SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-006973
Filing Date
2022-03-16
Accepted
2022-03-16 16:05:33
Documents
2
Period of Report
2022-03-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2222
2 ex24.htm EX-24 11060
  Complete submission text file 0001493152-22-006973.txt   14930
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address
Vazzano Joseph Walter (Reporting) CIK: 0001715291 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 22744890